VOGLIDIN M.3
VOGLIDIN M.3 contains Voglibose 0.3 mg + Metformin 500 mg, a dual-action combination designed to control type 2 diabetes effectively, especially after meals. Voglibose delays carbohydrate digestion to reduce post-meal sugar spikes, while Metformin lowers liver glucose production and improves insulin sensitivity. This combination helps achieve better blood sugar stability and supports long-term glycemic control in diabetic patients.
Related products
MUCINIL TAB
MUCINIL TAB contains N-Acetyl Cysteine 150 mg + Taurine 500 mg, a supportive formulation commonly...
LINANTA 5
LINANTA 5 contains Linagliptin 5 mg, an effective DPP-4 inhibitor used in the management of...
GLIPDIP M FORTE
GLIPDIP M FORTE is a combination therapy designed for better control of type 2 diabetes...
GLIBEN PM TAB
GLIBEN PM Tablet is a triple combination therapy used for effective management of type 2...
DUET ACT 2 FORTE
DUET ACT 2 FORTE Tablet is a combination medicine used for effective management of type...
DUET ACT 1
DUET ACT 1 contains Glimepiride 1 mg and Metformin 500 mg (SR). It works by...
DAPAGLIDE 10
DAPAGLIDE 10 Tablet contains Dapagliflozin 10 mg, an advanced medicine used to manage type 2...
CARBOSTOP 50
CARBOSTOP 50 Tablet is a combination medicine used for managing type 2 diabetes effectively. It...
